首站-论文投稿智能助手
典型文献
Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer:opportunities and challenges
文献摘要:
Breast cancer is globally the most common invasive cancer in women and remains one of the leading causes of cancer-related deaths. Surgery, radiotherapy, chemotherapy, immunotherapy, and endocrine therapy are currently the main treatments for this cancer type. However, some breast cancer patients are prone to drug resistance related to chemotherapy or immunotherapy, resulting in limited treatment efficacy. Consequently, traditional Chinese medicinal materials (TCMMs) as natural products have become an attractive source of novel drugs. In this review, we summarized the current knowledge on the active components of animal-derived TCMMs, including Ophiocordyceps sinensis-derived cordycepin, the aqueous and ethanolic extracts of O. sinensis, norcantharidin (NCTD), Chansu, bee venom, deer antlers, Ostrea gigas, and scorpion venom, with reference to marked anti-breast cancer effects due to regulating cell cycle arrest, proliferation, apoptosis, metastasis, and drug resistance. In future studies, the underlying mechanisms for the antitumor effects of these components need to be further investigated by utilizing multi-omics technologies. Furthermore, large-scale clinical trials are necessary to validate the efficacy of bioactive constituents alone or in combination with chemotherapeutic drugs for breast cancer treatment.
文献关键词:
作者姓名:
Chaochao YU;Yi LI;Guopeng CHEN;Chaoyan WU;Xiuping WANG;Yingwen ZHANG
作者机构:
Department of Integrated Chinese and Western Medicine,Zhongnan Hospital of Wuhan University,Wuhan University,Wuhan 430071,China;Department of Oncology,Zhongnan Hospital of Wuhan University,Wuhan University,Wuhan 430071,China;Department of Hematology,Zhongnan Hospital of Wuhan University,Wuhan University,Wuhan 430071,China
引用格式:
[1]Chaochao YU;Yi LI;Guopeng CHEN;Chaoyan WU;Xiuping WANG;Yingwen ZHANG-.Bioactive constituents of animal-derived traditional Chinese medicinal materials for breast cancer:opportunities and challenges)[J].浙江大学学报(英文版)(B辑:生物医学和生物技术),2022(07):547-563
A类:
TCMMs,Chansu,scorpion
B类:
Bioactive,constituents,animal,derived,traditional,Chinese,medicinal,materials,breast,cancer,opportunities,challenges,Breast,globally,most,common,invasive,women,remains,leading,causes,related,deaths,Surgery,radiotherapy,chemotherapy,immunotherapy,endocrine,are,currently,treatments,this,type,However,some,patients,prone,resistance,resulting,limited,efficacy,Consequently,natural,products,have,become,attractive,source,novel,drugs,In,review,summarized,knowledge,components,including,Ophiocordyceps,sinensis,cordycepin,aqueous,ethanolic,extracts,norcantharidin,NCTD,bee,venom,deer,antlers,Ostrea,gigas,reference,marked,effects,due,regulating,cell,cycle,arrest,proliferation,apoptosis,metastasis,future,studies,underlying,mechanisms,antitumor,these,need,further,investigated,by,utilizing,multi,omics,technologies,Furthermore,large,scale,clinical,trials,necessary,validate,bioactive,alone,combination,chemotherapeutic
AB值:
0.621532
相似文献
An international multicentric phase Ⅲ randomized controlled trial of time-acupoints-space acupuncture for the prevention of chemotherapy-induced fatigue in patients with early stage breast cancer:a study protocol
Saghachian Mahasti;Barry Caroline;Asselain Bernard;LI Yunfen;NIE Jianyun;LIU Dequan;CHEN Dedian;CHEN Chunxin;Laura Estevez;LI Wenhui;Jean-Pierre Armand;ZHU Miansheng;JU Liya-Institute Gustave Roussy,Paris,France;Research Center of Epidemiology and public health,Paris,France;Institute Curie of Paris,Paris,France;Yunnan Cancer Hospital,Third Affiliated Hospital of Kunming Medical University,Kunming,China;PreciMed Platform Europe,Paris,France,,MD Anderson Cancer Hospital,Madrid,Spain;ARIATAS Association pour la Recherche et l'Information de l'Acupuncture Time-Acupoints-Space,Paris,France
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD:A promising drug Potentilla discolor Bunge
Longshan Ji;Qian Li;Yong He;Xin Zhang;Zhenhua Zhou;Yating Gao;Miao Fang;Zhuo Yu;Robim M.Rodrigues;Yueqiu Gao;Man Li-Laboratory of Cellular Immunity,Institute of Clinical Immunology,Shanghai Key Laboratory of Traditional Chinese Medicine,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Key Laboratory of Liver and Kidney Diseases(Shanghai University of Traditional Chinese Medicine),Ministry of Education,Shanghai 201203,China;Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China;Department of Hepatopathy,Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine,Shanghai 201203,China;Department of in Vitro Toxicology and Dermato-Cosmetology,Faculty of Medicine and Pharmacy,Vrije Universiteit Brussel,Brussels 1000,Belgium
Novel dual inhibitor for targeting PIM1 and FGFR1 kinases inhibits colorectal cancer growth in vitro and patient-derived xenografts in vivo
Fanxiang Yin;Ran Zhao;Dhilli Rao Gorja;Xiaorong Fu;Ning Lu;Hai Huang;Beibei Xu;Hanyong Chen;Jung-Hyun Shim;Kangdong Liu;Zhi Li;Kyle Vaughn Laster;Zigang Dong;Mee-Hyun Lee-Department of Pathophysiology,School of Basic Medical Sciences,Zhengzhou University,Zhengzhou 450001,China;China-US(Henan)Hormel Cancer Institute,Zhengzhou 450008,China;Translational Medical Center,the First Affiliated Hospital of Zhengzhou University,Zhengzhou 450052,China;The Hormel Institute,University of Minnesota,Austin,MN 55912,USA;Department of Biomedicine,Health&Life Convergencen Science,BK21 Four,College of Pharmacy,Mokpo National University,Jeonnam 58554,Republic of Korea;The Collaborative Innovation Center of Henan Province for Cancer Chemoprevention,Zhengzhou 450001,China;Department of General Surgery,the Affiliated Tumor Hospital of Zhengzhou University,Zhengzhou 450008,China;College of Korean Medicine,Dongshin University,Naju 58245,Republic of Korea
Acquisition of taxane resistance by p53 inactivation in ovarian cancer cells
Changfa Shu;Xi Zheng;Alafate Wuhafu;Danielle Cicka;Sean Doyle;Qiankun Niu;Dacheng Fan;Kun Qian;Andrey A.Ivanov;Yuhong Du;Xiulei Mo;Haian Fu-Department of Pharmacology and Chemical Biology,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Gynecology and Obstetrics,The Third Xiangya Hospital of Central South University,Changsha 410013,China;Cancer Institute,the Second Affiliated Hospital,Zhejiang University School of Medicine,Hangzhou 310052,China;The First Affiliated Hospital,Medical School of Xi'an Jiaotong University,Xi'an 710061,China;Emory Chemical Biology Discovery Center,Emory University School of Medicine,Atlanta,GA 30322,USA;Department of Hematology and Medical Oncology and Winship Cancer Institute,Emory University,Atlanta,GA 30322,USA
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。